Skip to main content

CORRECTION article

Front. Pharmacol., 04 January 2023
Sec. Respiratory Pharmacology
Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.1036927
This article is part of the Research Topic Advances on Epigenetics Pharmacological Research for Chest-related Disease View all 4 articles

Corrigendum: Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial

This article is a correction to:

  1. Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial

    1. Read original article
Qinhai Ma&#x;Qinhai Ma1†Ruihan Chen,&#x;Ruihan Chen1,2†Jing Zeng&#x;Jing Zeng3†Biao LeiBiao Lei1Feng Ye Feng Ye1*Qihua WuQihua Wu3Zhengtu LiZhengtu Li1Yangqing ZhanYangqing Zhan1Bin LiuBin Liu1Bojun Chen Bojun Chen3*Zifeng Yang,, Zifeng Yang1,4,5*
  • 1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China
  • 2Faculty of Innovation Engineering, Macau University of Science and Technology, Taipa, Macao, China
  • 3The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
  • 4Guangzhou Laboratory, Guangdong, China
  • 5State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Taipa, Macau, China

A Corrigendum on
Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial

by Ma Q, Chen R, Lei B, Ye F, Li Z, Zhan Y, Liu B and Yang Z (2022). Front. Pharmacol. 13:968182. doi: 10.3389/fphar.2022.968182

In the published article, an error was made in the Title, “Investigating the effects of Liushen Capsules on the metabolome of seasonal influenza: A randomized clinical trial,” instead of “Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial.”

In the published article, there was an error in the Author list, and author “Jing Zeng, Qihua Wu and Bojun Chen” were erroneously excluded. The equal contributions of QM, RC, and JZ were also not signposted in the author list. The corrected author list appears below.

“Qinhai Ma1†, Ruihan Chen1,2†, Jing Zeng3†, Biao Lei1, Feng Ye1*, Qihua Wu3, Zhengtu Li1, Yangqing Zhan1, Bin Liu1, Bojun Chen3* and Zifeng Yang1,4,5*.”

In the published article, the following affiliation was not included “The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.”

In the published article, there was an error in Table 7 (Adverse events in LS and Placebo group during trial).

TABLE 7
www.frontiersin.org

TABLE 7. Adverse events in LS and Placebo group during trial.

The corrected Table 7 and its caption appear below.

A correction has been made to Author contributions, Paragraph Number 1503–1509. This statement previously stated:

“QM, ZY conceived and designed the study; QM, RC performed the study and analyzed the data; QM, RC, BLe wrote the paper; ZY, FY, ZL, YZ, BLi supervised the study and revised the manuscript. All authors read and approved the final manuscript.”

The corrected statement appears below:

“QM and ZY conceived and designed the study; BC, QM, RC, JZ, and QW performed the study, collected the clinical samples and analyzed the data; QM, RC, JZ, and BLe wrote the paper; ZY, BC, FY, ZL, YZ, and BLi supervised the study and revised the manuscript. All authors read and approved the final manuscript.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: influenza virus, liushen capsules, clinical trial, non-targeted metabolomics, Chinese traditional medicines

Citation: Ma Q, Chen R, Zeng J, Lei B, Ye F, Wu Q, Li Z, Zhan Y, Liu B, Chen B and Yang Z (2023) Corrigendum: Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial. Front. Pharmacol. 13:1036927. doi: 10.3389/fphar.2022.1036927

Received: 05 September 2022; Accepted: 13 December 2022;
Published: 04 January 2023.

Edited by:

Chia-Jung Li, Kaohsiung Veterans General Hospital, Taiwan

Reviewed by:

Jianguo Li, Shanxi University, China

Copyright © 2023 Ma, Chen, Zeng, Lei, Ye, Wu, Li, Zhan, Liu, Chen and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Feng Ye, yefeng@gird.cn; Bojun Chen, gzcbj@163.com; Zifeng Yang, jeffyah@163.com

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.